JEANNETTE HART: Open Payments
NPI 1962753830 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$78,987 in 147 payments from 11 companies in 2025. Trend: 2023 $49,659 · 2024 $81,908 · 2025 $78,987
Speaker / faculty: $50,238Travel & lodging: $18,934Consulting: $6,618Food & beverage: $3,198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 93 | $54,306 |
| Janssen Biotech, Inc. | 21 | $17,182 |
| AstraZeneca Pharmaceuticals LP | 13 | $4,647 |
| Eli Lilly and Company | 1 | $1,500 |
| GlaxoSmithKline, LLC. | 4 | $1,004 |
| Novartis Pharmaceuticals Corporation | 8 | $180 |
| UCB, Inc. | 2 | $53 |
| Amgen Inc. | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
Products named: RINVOQ, TREMFYA, SKYRIZI, SAPHNELO, TALTZ, BENLYSTA, COSENTYX, Bimzelx.
Industry payments across WA — which companies pay providers there.
